1xbet 한국 Pharmaceutical Co., Ltd.
Pharmaceuticals
August 8, 2011
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit '1xbet 한국' is Covered under Japanese Insurance Program, effective as of August.
1xbet 한국 Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that its WT1 mRNA Assay KitO 'tsuka', an in-vitro diagnostic kit by the quantitative real time RT-PCR method is now covered under the Japanese national health insurance program, effective on August 1, 2011, for Myelodysplastic Syndromes (MDS) in addition to Acute Myeloid Leukemia (AML).
Latest Pharmaceutical Bus1xbet 한국ess related News Releases